Overweight & Obesity

Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in heart and lung function essential for long-term good health, University of Virginia experts warn in a new paper.

What if we could prevent people from developing obesity? The World Obesity Federation expects more than half the global population to develop overweight or obesity by 2035. However, treatment strategies such as lifestyle change, surgery and medications are not universally available or effective.

A new study published in theCanadian Medical Association Journal found obesity rates based on body mass index (BMI) increased faster in the four years after the start of the pandemic than in the previous 11 years, especially in younger adults.

Intermittent energy restriction, time-restricted eating and continuous energy restriction can all improve blood sugar levels and body weight in people with obesity and type 2 diabetes, according to a study being presented Sunday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent muscle loss in these patients, according to a small study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide treatment alone, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.

New research shows that contrary to the fears of many parents, video games might be able to help children with obesity exercise more.

Research carried out on mice has revealed how a hormone released by the intestine acts on the brain and helps regulate the body’s energy expenditure. FGF19 (fibroblast growth factor 19) activates mechanisms that stimulate the use of more energy, burn fat, and favor weight control and blood glucose levels in obese animals.

A survey of adults living with obesity and their physicians across seven countries reveals a high disconnect between their perceptions about the causes of obesity and treatment goals. The findings being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May), highlight biased misconceptions about obesity which may impact patients’ access to treatment and support.

A new study led by York University, looking at the health data of nearly 15,000 people enrolled in a medically supervised weight-loss program, has found disparities among ethnic and sub-ethnic groups in how much weight they lost.